news

Researchers discover bronchospasms mechanisms using microdevice

A ‘bronchi-on-a-chip’ has been created by researchers to identify the processes of bronchospasms which could aid in respiratory disease therapies.

Researchers have identified how muscle contractions, or bronchospasms, occur in airways and for people with asthma. The study created a microdevice to make their discovery and believe it could aid in the development of treatments for respiratory diseases.

The research was conducted by Rutgers University, US, and other institutions. Developing a ‘bronchi-on-a-chip’, one-thousandth the size of a human hair, the team were able to study healthy and asthmatic lung cells.

When the researchers triggered a simulated bronchospasm on the device, they found that the initial contraction prompted the secretion of hormone-like compounds that either can induce an additional constriction or relax the spasm.

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

…inducing a second asthmatic trigger during a bronchial spasm at a precise time causes the smooth muscle to relax”

In people with asthma, the smooth muscle surrounding the airways is more reactive and contracts more easily in response to stimuli such as allergens, leading to extended bronchial spasms, wheezing and shortness of breath.

They also found that inducing a second asthmatic trigger during a bronchial spasm at a precise time causes the smooth muscle to relax, stopping the spasm.

“The microdevice allowed us to drill down into how single cells interact with each other in relation to smooth muscle contraction in a variety of lung diseases,” said co-author Reynold Panettieri, director of the Rutgers Institute for Translational Medicine and Science. “Being able to study the mechanics on the single-cell level and view thousands of cells simultaneously can be an important screening tool for the development of new drugs for people with asthma who don’t respond to current treatment.”

The study was published in Nature Biomedical Engineering.

Leave a Reply

Your email address will not be published. Required fields are marked *